OmniScience

OmniScience Corporation provides an AI-driven data intelligence platform designed for the life sciences sector, with a particular focus on clinical trials. The company's main offering is Vivo, a generative AI control tower that unifies and maps clinical trial data from various sources into a single portal. This allows clinical trial teams, including data managers, researchers, and safety monitors, to track data quality, identify risks, and gain immediate insights by asking questions in natural language, eliminating the need for complex queries or manual reporting.

The platform serves a range of clients, including biometrics teams, Contract Research Organizations (CROs), and clinical development leaders. It aims to shorten trial timelines, reduce operational costs, and accelerate the path to database lock by providing real-time access to harmonized data from systems like EDC, CTMS, and labs. The business model appears to be centered on providing this technology as a service to organizations conducting clinical trials.

The company was co-founded by Manu Shukla and Sunil Rawat, who serves as the CEO. Initially, OmniScience focused on providing an AI and distributed computing platform for the insurance and financial services industries, developing technology to analyze complex, hyperdimensional data without approximation for decision-making in areas like underwriting and risk management. This technological foundation, with origins in the US intelligence community, was designed to handle massive data volumes and combinatorial complexity. The company has since pivoted to apply its AI expertise to the life sciences and clinical trial domain.

Keywords: clinical trial data, generative AI, data unification, clinical development, data intelligence, life sciences AI, real-time analytics, trial risk management, CRO solutions, biometrics data, safety monitoring, e-clinical data, patient outcomes, data harmonization, AI data analyst